BrightSpring Health Services, Inc. (BTSG) vs 10x Genomics (TXG)
- BrightSpring Health Services, Inc. BTSG 60.87 −2.39%
- 10x Genomics TXG 69.86 −3.49%
BrightSpring Health Services, Inc. and 10x Genomics are both Health Information Services companies. BrightSpring Health Services, Inc. is the larger, with a market value of $12.3B against $9.4B — 1.3× the size. 10x Genomics has negative trailing earnings, so its P/E is not meaningful; BrightSpring Health Services, Inc. trades at 34.0×. BrightSpring Health Services, Inc. grew revenue faster over the last twelve months: 26.4% against −4.28%. BrightSpring Health Services, Inc. has the higher net margin (2.55% vs −12.2%) and the higher return on invested capital (7.56% vs −20.2%). Across the 18 metrics below, BrightSpring Health Services, Inc. leads on 14 and 10x Genomics on 4.
Valuation
Profitability
| Metric | BTSG | TXG | Health Information Services median |
|---|---|---|---|
| Gross margin | 12.38% | 70.03% | 62.87% |
| Operating margin | 3.12% | (14.33%) | (9.45%) |
| Net margin | 2.55% | (12.18%) | (15.48%) |
| Free cash flow margin | 2.80% | 19.68% | 0.00% |
| Return on equity | 19.31% | (9.40%) | (6.91%) |
| Return on assets | 6.14% | (7.47%) | (6.28%) |
| Return on invested capital | 7.56% | (20.20%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack